Celularity Inc.
CELU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $46 | $44 | $180 | $637 |
| - Cash | $1 | $0 | $14 | $37 |
| + Debt | $69 | $65 | $66 | $31 |
| Enterprise Value | $114 | $109 | $232 | $631 |
| Revenue | $54 | $23 | $18 | $21 |
| % Growth | 138.1% | 26.7% | -15.7% | – |
| Gross Profit | $39 | $7 | -$2 | $12 |
| % Margin | 72.4% | 29.7% | -9.4% | 54.8% |
| EBITDA | -$44 | -$184 | -$139 | -$88 |
| % Margin | -80.6% | -807.8% | -772.4% | -413% |
| Net Income | -$58 | -$196 | $14 | -$100 |
| % Margin | -106.8% | -862% | 79% | -469.3% |
| EPS Diluted | -2.645 | -11.02 | 0.947 | -14.93 |
| % Growth | 76% | -1,263.4% | 106.3% | – |
| Operating Cash Flow | -$6 | -$39 | -$138 | -$110 |
| Capital Expenditures | -$0 | -$4 | -$5 | -$6 |
| Free Cash Flow | -$7 | -$43 | -$143 | -$116 |